Clinical Trials & Research Studies in Canada(Updated 8/25)

Effect of Music on Surgical Performance During Artificial Intelligence-Based Simulation Training

NCT07111481

Recruiting

At the Neurosurgical Simulation and Artificial Intelligence Learning Centre, we seek to provide surgical trainees with innovative technologies that allow them to improve their surgical technical skills in risk-free environments, potentially improving patient operative outcomes. The Intelligent Continuous Expertise Monitoring System (ICEMS), a deep learning application that assesses and trains neurosurgical technical skill and provides continuous intraoperative feedback, is one such technology th... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: Neurosurgical Simulation and Artificial Intelligence Learning Centre, Montreal, Quebec

Conditions: Surgical Education

Register for Updates

Learn More ›

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

NCT04529122

Recruiting

WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: Instituto Alexander Fleming, Buenos Aires, Not set +133 locations

Instituto Alexander Fleming, Buenos Aires, Not set

CEMIC, Buenos Aires, Not set

Lkh-Univ. Klinikum Graz, Graz, Not set

Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul

Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo

Hospital Alemao Oswaldo Cruz, Sao Paulo, São Paulo

D'or Instituto de Pesquisa e Educação, Rio de Janeiro, Not set

Beneficencia Portuguesa de Sao Paulo, São Paulo, Not set

Alberta Health Services, Calgary, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Centro de Oncología de Precisión, Las Condes, Not set

Centro de Cancer Pontificie Universidad Catolica de Chile, Santiago, Not set

Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C., Not set

Fundacion Cardioinfantil, Bogota, Not set

Organizacion Sanitas Internacional, Bogota, Not set

Fundacion Clinica Valle del Lili, Cali, Not set

Instituto Cancerología Medellin, Medellin, Not set

Clinica ASTORGA, Medellin, Not set

International Medical Center, Cairo, Not set

East Tallinn Central Hospital, Tallinn, Not set

North Estonia Medical Centre Foundation, Tallinn, Not set

Tartu Uni Hospital, Tartu, Not set

Chu Amiens - Picardie, Amiens Cedex 1, Not set

Hopital Jean Minjoz, Besancon, Not set

Centre Hospitalier de Béthune-Beuvry, Bethune cedex, Not set

Chu Brest - Hôpital Morvan, Brest, Not set

Centre Francois Baclesse, Caen, Not set

Centre Jean Perrin, Clermont Ferrand, Not set

Groupe Hospitalier Public Du Sud De L'Oise GHPSO, Creil Cedex 1, Not set

Centre hospitalier universitaire Dijon-Bourgogne, Dijon, Not set

Hôpital Franco-Britannique- Fondation Cognacq-Jay, Levallois-Perret, Not set

Centre Oscar Lambret, Lille, Not set

Centre Leon Berard, Lyon, Not set

APHM, Marseille, Not set

Hopital de La Timone - CHU de Marseille, Marseille, Not set

Institut Régional du Cancer de Montpellier, Montpellier, Not set

Institut Curie, Paris, Not set

CH de Cornouailles, Quimper, Not set

Centre Eugene Marquis, Rennes, Not set

CHU Saint Etienne - Hôpital Nord, Saint Etienne, Not set

Hôpital Privé de la Loire, Ramsay Saint Etienne, St Etienne, Not set

CHI de Toulon - Hôpital Sainte Musse, Toulon, Not set

Gustave Roussy, Villejuif CEDEX, Not set

HELIOS Klinikum Bad Saarow, Bad Saarow, Not set

DRK Kliniken Berlin, Berlin, Not set

Universitätsklinikum Halle (Saale), Halle (Saale), Not set

Asklepios Klinik Altona, Hamburg, Not set

Medizinische Hochschule Hannover, Hannover, Not set

SLK-Kliniken Heilbronn GmbH;Klinik für Innere Medizin III, Heilbronn, Not set

Praxis für Hämatologie, Onkologie und Palliativmedizin, Mönchengladbach, Not set

Klinikum am Steinenberg / Ermstalklinik, Reutlingen, Not set

Katharinenhospital Stuttgart, Stuttgart, Not set

Marien-Hospital Wesel, Wesel, Not set

General Hospital "G.Papanikolaou", Asvestochori, Not set

Henri Dunant Hospital, Athens, Not set

Alexandras General Hospital of Athens, Athens, Not set

Metropolitan Hospital Fourth Oncology Clinic, Faliro, Not set

Bioclinic Thessaloniki, Thessaloniki, Not set

Bács-Kiskun Vármegyei Oktatókórház, Kecskemét, Not set

Pécsi Tudományegyetem, Pécs, Not set

Max Super Speciality Hospital, New Delhi, Delhi

Manipal Hospital, Bangalore, Karnataka

HealthCare Global Enterprises Limited, Banglore, Karnataka

Tata Memorial Hospital, Mumbai, Maharashtra

MOC Cancer Care & Research Centre (Unit of Cellcure Cancer Centre Pvt Ltd), Mumbai, Maharashtra

Bhaktivedanta Hospital and research institute, Thane, Maharashtra

Apollo Hospitals, Chennai, Tamil NADU

Indo-American Cancer Hospital & Research Center, Hyderabad, Telangana

Mid-Land Regional Hospital Tullamore, CO Offaly, Not set

Adelaide & Meath Hospital, Dublin, Incorporating the National Children's Hospital, Dublin, Not set

St Vincent'S Uni Hospital, Dublin, Not set

St James's Hospital, Dublin, Not set

Beacon Hospital, Dublin, Not set

Hadassah University Hospital - Ein Kerem, Jerusalem, Not set

Sourasky / Ichilov Hospital, Tel Aviv, Not set

American University of Beirut - Medical Center, Beirut, Not set

Hotel Dieu de France, Beirut, Not set

Hammoud Hospital, Saida, Not set

ONCARE Viaducto Napoles, Ciudad de México, Mexico CITY (federal District)

Clínica Integral Internacional de Oncología S de RL de CV, Puebla, Mexico CITY (federal District)

The American British Cowdray Hospital/ Hospital Abc, Mexico City, Not set

Cebu Doctors' University Hospital, Cebu City, Not set

Metro Davao Medical and Research Center, Davao City, Not set

St Lukes Medical Center, Quezon City, Not set

Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Warszawa, Not set

Hospital da Luz, Lisboa, Not set

Hospital CUF Porto, Porto, Not set

IPO do Porto, Porto, Not set

National Guard King Abdulaziz Medical City, Riyadh, Not set

University Hospital Medical Center Bezanijska kosa, Belgrade, Not set

Oncomed-System, Belgrade, Not set

SIRIUS Medical, Belgrade, Not set

Special hospital for internal diseases Vesalius, Belgrade, Not set

Oncology Institute of Vojvodina, Sremska Kamenica, Not set

Narodny Onkologicky Ustav, Bratislava, Not set

University Clinic Golnik, Golnik, Not set

Institute of Oncology Ljubljana, Ljubljana, Not set

Medical Oncology Centre of Rosebank, Johannesburg, Not set

Wilgers Oncology Centre, Pretoria, Not set

Hospital Universitario Son Espases, Palma De Mallorca, Islas Baleares

Clinica Universitaria de Navarra, Pamplona, Navarra

Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico, Jaen, Not set

Hospital Clinico Universitario Virgen de la Victoria;Servicio de Oncologia, Malaga, Not set

Hospital Universitario Miguel Servet, Zaragoza, Not set

Chang Gung Medical Foundation - Kaohsiung, Kaohisung, Not set

Taipei Veterans General Hospital, Taipei City, Not set

Chung Gung Memorial Hospital, Taoyuan County, Not set

Chulalongkorn Hospital, Bangkok, Not set

Faculty of Med. Siriraj Hosp., Bangkok, Not set

Medicana International Zincirlikuyu Hospital, Istanbul, Enter Text

Memorial Ankara Hastanesi, Ankara, Not set

Trakya University Medical Faculty, Edirne, Not set

Ba?c?lar Medipol Mega Üniversite Hastanesi, Istanbul, Not set

Medicana International Atasehir Hospital, Istanbul, Not set

Medicana International Izmir Hospital, Izmir, Not set

Ac?badem Maslak Hastanesi Büyükdere, Sar?yer/?stanbul, Not set

Ac?badem Adana Hospital, Oncology Department, Seyhan/Adana, Not set

Tawam Hospital, Al Ain, Not set

Mediclinic City Hospital, Dubai, Not set

Blackpool Victoria Hospital, Blackpool, Not set

Bristol Haematology and Oncology centre, Bristol, Not set

Royal Sussex County Hospital, Eastbourne, Not set

Royal Devon & Exeter Hospital, Exeter, Not set

Gloucestershire Royal Hospital, Gloucester, Not set

Royal Surrey County Hospital, Guildford, Not set

St Georges University Hospitals NHS Foundation Trust, London, Not set

Freeman Hospital, New Castle Upon Tyne, Not set

Mount Vernon Hospital, Northwood, Not set

Musgrove Park Hospital, Somerset, Not set

Kings Mill Hospital, Sutton in Ashfield, Not set

Torbay Hospital, Torquay, Not set

Hanoi Oncology Hospital, Hanoi, Not set

K hospital, Hanoi, Not set

Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Not set

Conditions: Solid Tumours

Register for Updates

Learn More ›

Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

NCT04855656

Recruiting

The primary purpose of this study is to assess the safety and tolerability of RP-6306 alone and in combination with RP-3500 or in combination with Debio 0123 in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) and assess preliminary anti-tumor activity.

Gender:

ALL

Ages:

12 years and above

Trial Updated:

08/01/2025

Locations: #1016, Mayo Clinic, Phoenix, Arizona +21 locations

Conditions: Advanced Solid Tumor

Register for Updates

Learn More ›

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Recruiting

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: City of Hope Comprehensive Cancer Center, Duarte, California +73 locations

City of Hope Comprehensive Cancer Center, Duarte, California

UCSD Moores Cancer Center, La Jolla, California

Chao Family Comprehensive Cancer Center UCI, Orange, California

Univ of Calif, San Francisco, San Francisco, California

Yale Cancer Center, New Haven, Connecticut

Florida Cancer Specialists - Sarasota, Sarasota, Florida

Dana Farber Cancer Institute, Boston, Massachusetts

Memorial Sloan Kettering Cancer Center, New York, New York

University of Oklahoma, Oklahoma City, Oklahoma

Abramson Cancer Center, Philadelphia, Pennsylvania

UPMC - Hillman Cancer Center, Pittsburgh, Pennsylvania

St Vincent's Hospital Sydney, Darlinghurst, New South Wales

Slade Health Inward goods, Mount Kuring-gai, New South Wales

Peter MacCallum Cancer Center, Melbourne, Victoria

Alfred Health, Melbourne, Victoria

Linear Clinical Research Limited, Nedlands, Western Australia

UZ Antwerpen, Edegem, Not set

CHU de Liège, Liège, Not set

AZ St Maarten Campus Leopoldstr, Mechelen, Not set

Santa Casa de Misericordia de Belo Horizonte - PPDS, Belo Horizonte, Minas Gerais

Hospital Erasto Gaertner, Curitiba, Paraná

Hospital de Clinicas de Porto Alegre HCPA PPDS, Porto Alegre, Pará

Universidade de Caxias do Sul, Caxias Do Sul, Rio Grande Do Sul

Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul (PUCRS), Porto Alegre, Rio Grande Do Sul

Hospital de Cancer de Barretos, Barretos, São Paulo

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, Sao Jose Do Rio Preto, São Paulo

Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo

Instituto Nacional de Câncer, Rio de Janeiro, Not set

Ottawa Hospital, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Jewish General Hospital, Montreal, Quebec

Semmelweis Egyetem, Budapest, Not set

Clinexpert Gyongyos Kft, Gyöngyös, Not set

Rambam Medical Center, Haifa, Not set

Sheba Medical Center - PPDS, Ramat Gan, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS, Meldola, Emilia-Romagna

Irccs Ospedale San Raffaele, Milano, Lombardia

Asst Grande Ospedale Metropolitano Niguarda, Milano, Lombardia

Istituto Clinico Humanitas, Rozzano (MI), Lombardia

Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana

Aga Khan University Hospital, Nairobi, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center - PPDS, Seoul, Not set

Samsung Medical Center - PPDS, Seoul, Not set

Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Not set

Leids Universitair Medisch Centrum, Leiden, Not set

Maastricht University Medical Center, Maastricht, Not set

Universitair Medisch Centrum Utrecht, Utrecht, Not set

Auckland City Hospital, Cancer and Blood Research, Auckland, Not set

Auckland City Hospital, Auckland, Not set

New Zealand Clinical Research - Christchurch, Christchurch, Not set

Haukeland University Hospital, Bergen, Not set

Oslo university hospital Radiumhospitalet, Oslo, Not set

Uniwersyteckie Centrum Kliniczne, O?rodek Bada? Klinicznych Wczesnych Faz, Gdansk, Not set

Biokinetica, Przychodnia Jozefow, Jozefow, Not set

Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?, Not set

Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan, Tatarstan

Hospital Universitari Vall d'Hebron, Barcelona, Not set

START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Not set

Hospital Clinico Universitario Virgen de la Victoria, Malaga, Not set

Hospital Universitario Virgen del Rocío, Sevilla, Not set

Hospital Clinico Universitario de Valencia, Valencia, Not set

Universitaetsspital Basel, Basel, Not set

Inselspital, Bern, Not set

Hôpitaux Universitaires de Genève, Genève, Not set

Unversitätsspital Zürich, Zürich, Not set

Queen Elizabeth Hospital, Birmingham, Not set

Velindre Cancer Centre, Cardiff, Not set

University College London Hospitals NHS Foundation Trust, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Advanced Solid Tumors

Register for Updates

Learn More ›

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

NCT05853367

Recruiting

The purpose of this study is to assess the efficacy, safety, and tolerability of MK-0472 administered as monotherapy and in combination with pembrolizumab (MK-3475) or MK-1084 in participants with histologically or cytologically confirmed diagnosis of advanced/metastatic solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: Northwestern Memorial Hospital ( Site 0002), Chicago, Illinois +24 locations

Northwestern Memorial Hospital ( Site 0002), Chicago, Illinois

The University of Louisville, James Graham Brown Cancer Center ( Site 0004), Louisville, Kentucky

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack, New Jersey

Rutgers Cancer Institute of New Jersey ( Site 0005), New Brunswick, New Jersey

Princess Margaret Cancer Centre ( Site 0101), Toronto, Ontario

Centre Hospitalier de l'Université de Montréal-Unit for Innovative Therapies ( Site 0100), Montréal, Quebec

Jewish General Hospital ( Site 0104), Montréal, Quebec

Bradfordhill ( Site 0702), Santiago., Region M. De Santiago

Centro de Estudios Clínicos SAGA ( Site 0701), Santiago, Region M. De Santiago

Fundacion Arturo Lopez Perez ( Site 0700), Santiago, Region M. De Santiago

Centro de Investigacion Clinicadela Universidad Catolica ( Site 0703), Santiago, Region M. De Santiago

Rambam Health Care Campus ( Site 0304), Haifa, Not set

Shaare Zedek Medical Center ( Site 0303), Jerusalem, Not set

Rabin Medical Center ( Site 0301), Petah Tikva, Not set

Sheba Medical Center ( Site 0300), Ramat Gan, Not set

Sourasky Medical Center ( Site 0302), Tel Aviv, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0401), Warszawa, Mazowieckie

Uniwersyteckie Centrum Kliniczne ( Site 0400), Gdansk, Pomorskie

Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 0501), L'Hospitalet de Llobregat, Cataluna

Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0504), Madrid, Madrid, Comunidad De

Hospital Universitari Vall d'Hebron ( Site 0500), Barcelona, Not set

Hospital Virgen del Rocio ( Site 0503), Sevilla, Not set

Hôpitaux Universitaires de Genève (HUG) ( Site 0202), Genève, Geneve

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 0201), St.Gallen, Sankt Gallen

Ospedale Regionale Bellinzona e Valli ( Site 0200), Bellinzona, Ticino

Conditions: Metastatic Solid Tumors, Advanced Solid Tumors

Register for Updates

Learn More ›

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

NCT06596694

Recruiting

Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are advanced (the cancer has spread to other parts of the body). The goals of this study are to learn: * About the safety and how well people tolerate of patritumab deruxtecan * How many people have the cancer respond (get smaller or go away) to treatment

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: UCLA Hematology Oncology Santa Monica ( Site 1205), Santa Monica, California +60 locations

UCLA Hematology Oncology Santa Monica ( Site 1205), Santa Monica, California

University of Colorado Cancer Center ( Site 1200), Aurora, Colorado

Sibley Memorial Hospital ( Site 1208), Washington, District of Columbia

University of Florida ( Site 1202), Gainesville, Florida

Mount Sinai Medical Center Comprehensive Cancer Center ( Site 1213), Miami Beach, Florida

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 1203), Marietta, Georgia

University of Chicago Medical Center ( Site 1204), Chicago, Illinois

Renown Regional Medical Center ( Site 1221), Reno, Nevada

NYU Langone Hospital - Long Island ( Site 1230), Mineola, New York

Perlmutter NYU Cancer Center ( Site 1212), New York, New York

Scott & White Medical Center-Temple ( Site 1224), Temple, Texas

Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 1207), Roanoke, Virginia

University of Wisconsin ( Site 1210), Madison, Wisconsin

Westmead Hospital ( Site 0100), Sydney, New South Wales

Alfred Health ( Site 0102), Melbourne, Victoria

Austin Health ( Site 0103), Melbourne, Victoria

One Clinical Research ( Site 0104), Mount Pleasant, Western Australia

QEII Health Sciences Centre - Victoria General Site ( Site 0200), Halifax, Nova Scotia

McGill University Health Centre ( Site 0202), Montreal, Quebec

Fundacion Arturo Lopez Perez ( Site 0301), Santiago., Region M. De Santiago

Centro de Oncología de Precisión ( Site 0305), Santiago, Region M. De Santiago

Clínica UC San Carlos de Apoquindo ( Site 0302), Santiago, Region M. De Santiago

Bradfordhill ( Site 0300), Santiago, Region M. De Santiago

The First Affiliated Hospital of Anhui Medical University ( Site 0405), Hefei, Anhui

Fujian Provincial Cancer Hospital ( Site 0408), Fuzhou, Fujian

Zhongshan Hospital Fudan University (Xiamen Branch) ( Site 0412), Xiamen, Fujian

Southern Medical University Nanfang Hospital ( Site 0413), Fuzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University ( Site 0404), Guangzhou, Guangdong

Affiliated Cancer Hospital of Guangxi Medical University ( Site 0411), Nanning, Guangxi

Henan Cancer Hospital ( Site 0403), Zhengzhou, Henan

Zhongshan Hospital,Fudan University ( Site 0400), Shanghai, Shanghai

First Hospital of Shanxi Medical University ( Site 0409), Tai Yuan, Shanxi

Hopital Beaujon ( Site 0500), Clichy, Hauts-de-Seine

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 0501), Rennes, Ille-et-Vilaine

Hopital de la Croix Rousse ( Site 0502), Lyon, Rhone-Alpes

Rambam Health Care Campus ( Site 0603), Haifa, Not set

Sourasky Medical Center ( Site 0601), Tel Aviv, Not set

Hadassah Medical Center ( Site 0602), Yerushalayim, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0700), Milano, Not set

ASST Grande Ospedale Metropolitano Niguarda ( Site 0701), Milano, Not set

Fondazione Policlinico Universitario Agostino Gemelli ( Site 0702), Roma, Not set

Seoul National University Hospital ( Site 0900), Seodaemun-gu, Seoul

Severance Hospital, Yonsei University Health System ( Site 0903), Seoul, Not set

Asan Medical Center ( Site 0902), Seoul, Not set

Samsung Medical Center ( Site 0901), Seoul, Not set

Harbour Cancer & Wellness ( Site 0800), Auckland, Not set

Hospital Central de Asturias ( Site 1001), Oviedo, Asturias

Hospital Universitari Vall d'Hebron ( Site 1000), Barcelona, Not set

Hospital Universitario Gregorio Maranon ( Site 1002), Madrid, Not set

Hospital Clinico San Carlos... ( Site 1003), Madrid, Not set

Hopitaux Universitaires de Geneve HUG. ( Site 1102), Geneve, Not set

Universitaetsspital Zuerich ( Site 1105), Zurich, Not set

National Cheng Kung University Hospital-Clinical Trial Center ( Site 1502), Tainan, Not set

National Taiwan University Hospital ( Site 1500), Taipei, Not set

Taipei Veterans General Hospital ( Site 1501), Taipei, Not set

Faculty of Medicine Siriraj Hospital ( Site 1301), Bangkoknoi, Krung Thep Maha Nakhon

Ramathibodi Hospital ( Site 1302), Ratchathewi, Krung Thep Maha Nakhon

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 1400), Yenimahalle, Ankara

Dokuz Eylul Universitesi Hastanesi ( Site 1402), Balcova, Izmir

Adana City Hospital ( Site 1404), Adana, Not set

Hacettepe Universite Hastaneleri ( Site 1401), Ankara, Not set

Conditions: Gastrointestinal Cancer

Register for Updates

Learn More ›

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Recruiting

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

08/01/2025

Locations: Total Skin and Beauty Dermatology Center PC, Birmingham, Alabama +96 locations

Total Skin and Beauty Dermatology Center PC, Birmingham, Alabama

CTT Research, Gilbert, Arizona

Ctr Dermatology and Plastic Surgery, Scottsdale, Arizona

Ctr for Dermatology Clinical Res, Fremont, California

USC Keck School of Medicine, Los Angeles, California

MedDerm Associates, San Diego, California

Driven Research, Coral Gables, Florida

Floridian Research Institute, Miami, Florida

Sarasota Arthritis Res Ctr, Sarasota, Florida

University Of South Florida, Tampa, Florida

Emory School of Med Dermatology, Atlanta, Georgia

Endeavor Health, Glenview, Illinois

Dundee Dermatology, West Dundee, Illinois

Southern IN Clinical Trials, New Albany, Indiana

Metro Boston Clinical Partners, Brighton, Massachusetts

Clinical Research Inst of MI, Chesterfield, Michigan

Skin Specialists PC, Omaha, Nebraska

Vivida Dermatology, Las Vegas, Nevada

North Shore University Hospital, New Hyde Park, New York

Cameron Dermatology, New York, New York

Optima Research Boardman, Boardman, Ohio

Ohio State University, Columbus, Ohio

Wright State University, Fairborn, Ohio

Apex Clinical Research Center LLC, Mayfield Heights, Ohio

Clinical Research Ctr of Carolinas, Charleston, South Carolina

Rivergate Dermatology and Skin Care Center, Goodlettsville, Tennessee

Accurate Clinical Research, Humble, Texas

Austin Inst for Clinical Research, Pflugerville, Texas

Center for Clinical Studies-Lee, Webster, Texas

Care Access Alexandria, Arlington, Virginia

Complexions Dermatology, Danville, Virginia

Forefront Dermatology, Vienna, Virginia

Novartis Investigative Site, Caba, Not set

Novartis Investigative Site, Linz, Not set

Novartis Investigative Site, Leuven, Not set

Novartis Investigative Site, Liege, Not set

Novartis Investigative Site, Edmonton, Alberta

Novartis Investigative Site, London, Ontario

Novartis Investigative Site, Montreal, Quebec

Novartis Investigative Site, Sherbrooke, Quebec

Novartis Investigative Site, Quebec, Not set

Novartis Investigative Site, Karlovy Vary, Czech Republic

Novartis Investigative Site, Prague 8, Czech Republic

Novartis Investigative Site, Plzen Bolevec, Not set

Novartis Investigative Site, Praha 10, Not set

Novartis Investigative Site, Praha 2, Not set

Novartis Investigative Site, Praha, Not set

Novartis Investigative Site, Brest, Not set

Novartis Investigative Site, La Rochelle, Not set

Novartis Investigative Site, Lyon, Not set

Novartis Investigative Site, Nice, Not set

Novartis Investigative Site, Reims, Not set

Novartis Investigative Site, Rouen, Not set

Novartis Investigative Site, Toulouse, Not set

Novartis Investigative Site, Merzig, Saarland

Novartis Investigative Site, Leipzig, Sachsen

Novartis Investigative Site, Bad Bentheim, Not set

Novartis Investigative Site, Dessau-Rosslau, Not set

Novartis Investigative Site, Dortmund, Not set

Novartis Investigative Site, Duesseldorf, Not set

Novartis Investigative Site, Essen, Not set

Novartis Investigative Site, Freiburg, Not set

Novartis Investigative Site, Hamburg, Not set

Novartis Investigative Site, Luebeck, Not set

Novartis Investigative Site, Minden, Not set

Novartis Investigative Site, Muenchen, Not set

Novartis Investigative Site, Tuebingen, Not set

Novartis Investigative Site, Wuerzburg, Not set

Novartis Investigative Site, Thessaloniki, GR

Novartis Investigative Site, Athens, Not set

Novartis Investigative Site, Budapest, Not set

Novartis Investigative Site, Debrecen, Not set

Novartis Investigative Site, Kecskemet, Not set

Novartis Investigative Site, Pecs, Not set

Novartis Investigative Site, Szeged, Not set

Novartis Investigative Site, Ipoh, Perak

Novartis Investigative Site, Kota Kinabalu, Sabah

Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan

Novartis Investigative Site, Johor Bahru, Not set

Novartis Investigative Site, Selangor Darul Ehsan, Not set

Novartis Investigative Site, Wilayah Persekutuan, Not set

Novartis Investigative Site, Warsaw, Not set

Novartis Investigative Site, Warszawa, Not set

Alma Cruz-Santana Private Practice, Carolina, Not set

Novartis Investigative Site, Bucharest, District 2

Novartis Investigative Site, Sevilla, Andalucia

Novartis Investigative Site, Palma De Mallorca, Islas Baleares

Novartis Investigative Site, Granollers, Not set

Novartis Investigative Site, Las Palmas de Gran Canaria, Not set

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, Pontevedra, Not set

Conditions: Hidradenitis Suppurativa

Register for Updates

Learn More ›

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

NCT05800665

Recruiting

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regimens for RO7656594 for subsequent studies.

Gender:

MALE

Ages:

18 years and above

Trial Updated:

08/01/2025

Locations: HonorHealth, Scottsdale, Arizona +24 locations

HonorHealth, Scottsdale, Arizona

Yale Cancer Center, New Haven, Connecticut

Sarah Cannon Research Institute @ Florida Cancer, Orlando, Florida

University of Illinois Hospital & Health Sciences System, Chicago, Illinois

Tennessee Oncology - Nashville, Nashville, Tennessee

St Vincent's Hospital Sydney, Darlinghurst, New South Wales

Monash Health Monash Medical Centre, Clayton, Victoria

Austin Hospital, Heidelberg, Victoria

Macquarie University Hospital, New South Wales, Not set

British Columbia Cancer Agency, Vancouver, British Columbia

Princess Margaret Hospital, Toronto, Ontario

Centre Léon Bérard, Lyon, Not set

Institut Paoli Calmettes, Marseille, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System - PPDS, Seoul, Not set

Asan Medical Center - PPDS, Seoul, Not set

Samsung Medical Center - PPDS, Seoul, Not set

Clinica Universidad de Navarra, Pamplona, Navarra

Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Not set

Clinica Universidad de Navarra-Madrid, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Cambridge Clinical Research Centre, Cambridge, Not set

Leicester Royal Infirmary, Leicester, Not set

The Christie, Manchester, Not set

Royal Marsden Hospital - Surrey, Sutton, Not set

Conditions: Advanced Prostate Cancer, Metastatic Prostate Cancer

Register for Updates

Learn More ›

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524

Recruiting

This is a Phase III, multicenter, open-label clinical study designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab prophylaxis in participants aged 2 years and above, who have been diagnosed with Type 3 von Willebrand disease (VWD). Participants on prior standard of care (SOC) on-demand therapy will be assessed via a randomized comparison (Arm A - emicizumab prophylaxis and Arm B - continuation of SOC on-demand therapy), while participants on prior SOC pr... Read More

Gender:

ALL

Ages:

2 years and above

Trial Updated:

08/01/2025

Locations: UZ Leuven Gasthuisberg, Leuven, Not set +8 locations

Conditions: Von Willebrand Disease, Type 3

Register for Updates

Learn More ›

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

NCT03938987

Recruiting

Autologous, unselected CD3+ lymphocytes collected from apheresis, transfected with a lentiviral vector containing a 2nd generation chimeric antigen receptor (CAR) consisting of a scFv recognizing CD19 and dual co-stimulatory intracellular signaling domains (4-1BB and CD3ζ).

Gender:

ALL

Ages:

Between 2 years and 70 years

Trial Updated:

07/31/2025

Locations: Foothills Medical Centre, Calgary, Alberta +5 locations

Conditions: Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL

Register for Updates

Learn More ›

Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome

NCT04524585

Recruiting

PNEUMA is a preliminary safety and feasibility trial of a novel approach to the titration of neuromuscular blockade (NMB) to safe spontaneous breathing in patients with severe acute respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane oxygenation (VV-ECMO).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/31/2025

Locations: University Health Network, Toronto, Ontario

Conditions: Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Neuromuscular Blockade

Register for Updates

Learn More ›

Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma

NCT06341712

Recruiting

The participants of this study will be children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery. Participants will have achieved a partial response or stable disease at the end of conventional chemotherapy. Osteosarcoma is cancer of the bone. The cancer cells make immature bone cells, known as osteoid. Osteosarcoma is very rare, but it is the most common type of bone cancer in children and teens. It is most common in teens and young... Read More

Gender:

ALL

Ages:

Between 5 years and 30 years

Trial Updated:

07/31/2025

Locations: University of Southern California (USC) - Norris Cancer Hospital, Los Angeles, California +73 locations

University of Southern California (USC) - Norris Cancer Hospital, Los Angeles, California

Stanford University and Lucile Packard Children's Hospital, Palo Alto, California

University of Florida Health Shands Children's Hospital, Gainesville, Florida

Levine Children's Hospital (LCH), Charlotte, North Carolina

Cincinnati Children's Hospital Medical Center - Cancer and Blood Diseases Institute (CBDI), Cincinnati, Ohio

MD Anderson Main Campus, Houston, Texas

Children's Hospital of the King's Daughters, Norfolk, Virginia

St. Anna Kinderspital Zentrum fuer Kinder- und Jugendheilkunde, Vienna, Not set

Cliniques universitaires Saint-Luc, Bruxelles, Not set

University Hospital Gent, Ghent, Not set

Universitaire Ziekenhuizen Leuven, Leuven, Not set

Arthur J. E. Child Comprehensive Cancer Centre, Calgary, Not set

McGill University Health Centre - Centre for Innovative Medicine, Québec, Not set

Princess Margaret cancer center, Toronto, Not set

Sinai Health System-Mount Sinai Hospital, Toronto, Not set

Aarhus University Hospital, Aarhus, Not set

Copenhagen University Hospital - Rigshospitalet, Kobenhavn, Not set

Institut Bergonie, Bordeaux, Not set

Centre Francois Baclesse, Caen, Not set

Centre Oscar Lambret, Lille, Not set

Centre Leon Berard, Lyon, Not set

CHU de Nantes, Nantes, Not set

AP-HP Hopital Cochin, Paris, Not set

Institut Curie, Paris, Not set

CHU de Poitiers (Poitiers), Poitiers, Not set

CHU de Poitiers, Poitiers, Not set

CHU de Rouen - Hôpital Charles-Nicolle, Rouen, Not set

CHRU de Strasbourg - Hopital de Hautepierre, Strasbourg, Not set

CHU de Toulouse - Hôpital des Enfants, Toulouse, Not set

Gustave Roussy, Villejuif, Not set

Charité - Kinderonkologie, Berlin, Not set

Klinikum Dortmund, Dortmund, Not set

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Not set

Universitätsklinikum Essen Westdeutsches Tumorzentrum Essen, Essen, Not set

Klinikum Kassel Gesundheit Nordhessen, Kassel, Not set

Universitaetsklinikum Köln - Kinderonkologie, Köln, Not set

Universitätsmedizin Mainz, Mainz, Not set

Klinikum rechts der Isar der Technischen Universitaet Muenchen, Muenchen, Not set

Dr. von Haunerschen Kinderspital, München, Not set

Medizinischen Klinik III - Onkologie und Hämatologie - am LMU Klinikum, München, München, Not set

Olgahospital, Stuttgart, Not set

St Vincent's University Hospital, Dublin, Not set

Ospedale Ortopedico Rizzoli di Bologna, Bologna, Not set

Azienda Ospedaliero Universitaria Meyer, Firenze, Not set

IRCCS Istituto Giannina Gaslini, Genova, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Not set

Istituto Nazionale Tumor, Naples, Not set

Azienda Ospedale - Università Padova, Padova, Not set

AOU Città della Salute e della Scienza di Torino, Piemonte, Not set

IRCCS - Istituto Nazionale Tumori Regina Elena, Roma, Not set

Ospedale Paediatrico Bambino Gesù, Roma, Not set

Azienda Ospedaliero-Universitaria Senese, Siena, Not set

AOU Citta della Salute e della Scienza di Torino - Ospedale Regina Margherita, Torino, Not set

Amsterdam UMC - Locatie AMC, Amsterdam, Not set

Princess Maxima Center for paediatric oncology, Utrecht, Not set

Instytut Matki i Dziecka, Warsaw, Not set

Hospital de La Santa Creu i Sant Pau, Barcelona, Not set

Hospital Sant Joan de Deu, Barcelona, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Hospital Universitario La Paz, Castellana, Not set

Hospital General Unversitario Gregorio Marañón (Madrid), Madrid, Not set

Hospital General Unversitario Gregorio Marañón, Madrid, Not set

Hospital Infantil Universitario Nino Jesus, Madrid, Not set

Hospital Universitario Son Espases, Palma De Mallorca, Not set

Complejo Hospitalario Universitario de Santiago, Santiago De Compostela, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Karolinska University Hospital, Stockholm, Not set

Birmingham Children's Hospital, Birmingham, Not set

Cambridge University Hospitals NHS Trust, Cambridge, Not set

NHS greater Glasgow and Clyde, Glasgow, Not set

University College London Hospital, London, Not set

Christie NHS Foundation Trust, Manchester, Not set

Royal Victoria Infirmary, Newcastle Upon Tyne, Not set

Conditions: Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults

Register for Updates

Learn More ›

All Clinical Trials in Canada

Match to Clinical Trials